Literature DB >> 21910177

Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994-2007).

Eric I Benchimol1, Astrid Guttmann, Teresa To, Linda Rabeneck, Anne M Griffiths.   

Abstract

BACKGROUND: Recent advances have been made in the care of children with inflammatory bowel disease (IBD). We aimed to describe trends in medication use, associated health services, and outcomes (hospitalization and surgical rates) between 1994-2007 in children with IBD.
METHODS: Children <18 years diagnosed 1994-2004 with IBD living in Ontario were identified and grouped by era of diagnosis (1994-1997, 1998-2000, 2001-2004). We tested the association between era and hospitalizations and surgery. Medication use (in children on social assistance), and physician provider specialty were described.
RESULTS: IBD-related outpatient health services were increasingly provided by pediatric gastroenterologists, with decreasing care by adult gastroenterologists, surgeons, and generalists. Children diagnosed in 2001-2004 with Crohn's disease (CD) were more likely to use an immunomodulator within 3 years of diagnosis (P = 0.01). In all children with IBD, numbers of hospitalizations and physician visits remained stable over time; however, the age-adjusted odds of being hospitalized was higher in recent years for CD (adjusted odds ratio [aOR] 3.22, 95% confidence intervals [CI] 2.15-4.83) and ulcerative colitis (UC) (aOR 2.83 95% CI 1.55-5.19). Surgical rates within 3 years of diagnosis with CD decreased from 18.8% to 13.6% over time (P = 0.035). This decrease was significant in children with CD diagnosed ≥10 years old (aOR 0.67, 95% CI 0.48-0.93). No change was demonstrated in UC.
CONCLUSIONS: Treatment changes in children with IBD between 1994-2007 (including increased immunomodulator use and increased outpatient care by pediatric gastroenterologists) were associated with reduced surgical rates in children with CD but not UC.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21910177     DOI: 10.1002/ibd.21591

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  15 in total

Review 1.  Role of surgery in pediatric ulcerative colitis.

Authors:  Emanuela Ceriati; Francesco De Peppo; Massimo Rivosecchi
Journal:  Pediatr Surg Int       Date:  2013-10-31       Impact factor: 1.827

Review 2.  Inflammatory bowel disease: a Canadian burden of illness review.

Authors:  Angela Rocchi; Eric I Benchimol; Charles N Bernstein; Alain Bitton; Brian Feagan; Remo Panaccione; Kevin W Glasgow; Aida Fernandes; Subrata Ghosh
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

3.  Life expectancy and health-adjusted life expectancy in people with inflammatory bowel disease.

Authors:  M Ellen Kuenzig; Douglas G Manuel; Jessy Donelle; Eric I Benchimol
Journal:  CMAJ       Date:  2020-11-09       Impact factor: 8.262

4.  Increasing hospitalizations in inflammatory bowel disease among children in the United States, 1988-2011.

Authors:  Kelly C Sandberg; Matthew M Davis; Achamyeleh Gebremariam; Jeremy Adler
Journal:  Inflamm Bowel Dis       Date:  2014-10       Impact factor: 5.325

5.  Low trypsinogen-1 expression in pediatric ulcerative colitis patients who undergo surgery.

Authors:  Maija Piekkala; Jaana Hagström; Maarit Tanskanen; Risto Rintala; Caj Haglund; Kaija-Leena Kolho
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

6.  Resection leads to less recurrence than strictureplasty in a paediatric population with obstructive Crohn's disease.

Authors:  Richard Bamford; Ashley Hay; Devinder Kumar
Journal:  Surg Res Pract       Date:  2014-04-01

7.  Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study.

Authors:  Eric I Benchimol; M Ellen Kuenzig; Charles N Bernstein; Geoffrey C Nguyen; Astrid Guttmann; Jennifer L Jones; Beth K Potter; Laura E Targownik; Christina A Catley; Zoann J Nugent; Divine Tanyingoh; Nassim Mojaverian; Fox E Underwood; Shabnaz Siddiq; Anthony R Otley; Alain Bitton; Matthew W Carroll; Jennifer C deBruyn; Trevor Jb Dummer; Wael El-Matary; Anne M Griffiths; Kevan Jacobson; Desmond Leddin; Lisa M Lix; David R Mack; Sanjay K Murthy; Juan Nicolás Peña-Sánchez; Harminder Singh; Gilaad G Kaplan
Journal:  Clin Epidemiol       Date:  2018-11-08       Impact factor: 4.790

Review 8.  Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-Based Cohorts.

Authors:  Lester Tsai; Christopher Ma; Parambir S Dulai; Larry J Prokop; Samuel Eisenstein; Sonia L Ramamoorthy; Brian G Feagan; Vipul Jairath; William J Sandborn; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2020-10-27       Impact factor: 13.576

9.  Genetic variants associated with Crohn's disease.

Authors:  Sonia Michail; Gilberto Bultron; R William Depaolo
Journal:  Appl Clin Genet       Date:  2013-07-16

10.  The Challenges of Living with Inflammatory Bowel Disease: Summary of a Summit on Patient and Healthcare Provider Perspectives.

Authors:  Judith Bray; Aida Fernandes; Geoffrey C Nguyen; Anthony R Otley; Joan Heatherington; Jennifer Stretton; Natasha Bollegala; Eric I Benchimol
Journal:  Can J Gastroenterol Hepatol       Date:  2016-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.